Unexploited Viral and Host Targets for the Treatment of Human Immunodeficiency Virus Type 1 Infection

Publisher： Bentham Science Publishers

E-ISSN： 1875-5852|1|2|107-123

ISSN： 1568-0053

Source： Current Drug Targets - Infectious Disorders, Vol.1, Iss.2, 2001-08, pp. : 107-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection

By Kaplan Susan S   Hicks Charles B  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1573-1585

Informa Healthcare

Access to resources Recommend Favorite

Drug Targets in Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 2, 2009-04 ,pp. : 159-171

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Polymorphisms in the Chemokine and Chemokine Receptors: Impact on Clinical Course and Therapy of the Human Immunodeficiency Virus Type 1 Infection (HIV-1)

By  

Current Medicinal Chemistry, Vol. 14, Iss. 12, 2007-05 ,pp. : 1325-1334

Bentham Science Publishers

Access to resources Recommend Favorite

Dimerization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase as an Antiviral Target

By  

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-05 ,pp. : 1879-1894

Bentham Science Publishers

Access to resources Recommend Favorite

Nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-05 ,pp. : 895-919

Bentham Science Publishers

Access to resources Recommend Favorite